Urotensin II (Human) (0.5 mg vial)

Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint, J.C. Beauvillain, J.M. Conlon, H.A. Bern, and H. Vaudry, Proc. Natl. Acad. Sci. U.S.A., 95, 15803 (1998). (Original)

R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, A.M. Romanic, C.S. Louden, J.J. Foley, C.F. Sauermelch, R.W. Coatney, Z. Ao, J. Disa, S.D. Holmes, J.M. Stadel, J.D. Martin, W.-S. Liu, G.I. Glover, S. Wilson, D.E. McNulty, C.E. Ellis, N.A. Elshourbagy, U. Shabon, J.J. Trill, D.W.P. Hay, E.H. Ohlstein, D.J. Bergsma, and S.A. Douglas, Nature, 401, 282 (1999). (Pharmacol.)

M.R. MacLean, D. Alexander, A. Stirrat, M. Gallagher, S.A. Douglas, E.H. Ohlstein, I. Morecroft, and K. Polland, Br. J. Pharmacol., 130, 201 (2000). (Pharmacol.)